share_log

阿里健康：截至2024年4月30日之股份發行人的證券變動月報表

ALI HEALTH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024

HKEX ·  May 3 14:48
Summary by Futu AI
阿里健康信息技術有限公司於2024年5月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，法定/註冊股本總額維持在200,000,000港元，普通股股份數目仍為20,000,000,000股。此外，報告亦提及公司股份期權計劃的情況，包括自2014年至2023年間授出的股份獎勵特別授權，以及因行使期權所得資金總額為零。公司確認，所有證券發行均已獲董事會正式授權批准，並符合相關上市規則的要求。
阿里健康信息技術有限公司於2024年5月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，法定/註冊股本總額維持在200,000,000港元，普通股股份數目仍為20,000,000,000股。此外，報告亦提及公司股份期權計劃的情況，包括自2014年至2023年間授出的股份獎勵特別授權，以及因行使期權所得資金總額為零。公司確認，所有證券發行均已獲董事會正式授權批准，並符合相關上市規則的要求。
Ali Health Information Technology Limited filed with Hong Kong Trading and Settlement Limited on 3 May 2024 with Hong Kong Exchanges and Settlements Limited, reporting the changes in the company's share capital as of 30 April 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, WITH THE STATUTORY/REGISTERED SHARE CAPITAL REMAINING AT HK$200,000,000 AND THE NUMBER OF ORDINARY SHARES REMAINED AT 20,000,000,000 SHARES. In addition, the report also mentions the situation of the Company's stock option plan, including the special share award authorization granted from 2014 to 2023, and the total amount of capital generated from the exercise of options of zero. The Company confirms that all securities issues have been formally authorized by the Board of Directors and comply with the requirements of the relevant Listing Rules.
Ali Health Information Technology Limited filed with Hong Kong Trading and Settlement Limited on 3 May 2024 with Hong Kong Exchanges and Settlements Limited, reporting the changes in the company's share capital as of 30 April 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, WITH THE STATUTORY/REGISTERED SHARE CAPITAL REMAINING AT HK$200,000,000 AND THE NUMBER OF ORDINARY SHARES REMAINED AT 20,000,000,000 SHARES. In addition, the report also mentions the situation of the Company's stock option plan, including the special share award authorization granted from 2014 to 2023, and the total amount of capital generated from the exercise of options of zero. The Company confirms that all securities issues have been formally authorized by the Board of Directors and comply with the requirements of the relevant Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.